Structure of Leishmania mexicana Phosphomannomutase Highlights Similarities with Human Isoforms

Journal of Molecular Biology

Volumn 363, Issue 1, 2006, Pages 215-227

  Kedzierski, Lukasz ^a   Malby, Robyn L ^a   Smith, Brian J ^a   Perugini, Matthew A ^b   Hodder, Anthony N ^a   Ilg, Thomas ^c   Colman, Peter M ^a   Handman, Emanuela ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c Intervet Innovation GmbH   (Germany)

Author keywords

crystal structure; Leishmania; mannose; phosphomannomutase; virulence

Indexed keywords

GLUCOSE 1,6 BISPHOSPHATE; ISOPROTEIN; PHOSPHOMANNOMUTASE;

ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; ENZYME STRUCTURE; GENE EXPRESSION; LEISHMANIA MEXICANA; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; STRUCTURE ANALYSIS; VIRULENCE;

EUKARYOTA; LEISHMANIA MAJOR; LEISHMANIA MEXICANA;

EID: 33748958831     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2006.08.023     Document Type: Article

References (57)

1. Handman E. Cell biology of Leishmania. Adv. Parasitol. 44 (1999) 1-39
2. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp. Immunol. Microbiol. Infect. Dis. 27 (2004) 305-318
3. Murray H.W., Berman J.D., Davies C.R., and Saravia N.G. Advances in leishmaniasis. Lancet 366 (2005) 1561-1577
4. Sundar S., More D.K., Singh M.K., Singh V.P., Sharma S., Makharia A., et al. Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic. Clin. Infect. Dis. 31 (2000) 1104-1107
5. Davis A.J., and Kedzierski L. Recent advances in anti-leishmanial drug development. Curr. Opin. Investig. Drugs 6 (2005) 163-169
6. Collet J.F., Stroobant V., Pirard M., Delpierre G., and Van Schaftingen E. A new class of phosphotransferases phosphorylated on an aspartate residue in an amino-terminal DXDX(T/V) motif. J. Biol. Chem. 273 (1998) 14107-14112
7. Oesterhelt C., Schnarrenberger C., and Gross W. The reaction mechanism of phosphomannomutase in plants. FEBS Letters 401 (1997) 35-37
8. Carchon H., Van Schaftingen E., Matthijs G., and Jaeken J. Carbohydrate-deficient glycoprotein syndrome type IA (phosphomannomutase-deficiency. Biochim. Biophys. Acta 1455 (1999) 155-165
9. Pirard M., Achouri Y., Collet J.F., Schollen E., Matthijs G., and Van Schaftingen E. Kinetic properties and tissular distribution of mammalian phosphomannomutase isozymes. Biochem. J. 339 (1999) 201-207
10. Kepes F., and Schekman R. The yeast SEC53 gene encodes phosphomannomutase. J. Biol. Chem. 263 (1988) 9155-9161
11. Goldberg J.B., Coyne Jr. M.J., Neely A.N., and Holder I.A. Avirulence of a Pseudomonas aeruginosa algC mutant in a burned-mouse model of infection. Infect. Immun. 63 (1995) 4166-4169
12. Freeze H.H., and Aebi M. Molecular basis of carbohydrate-deficient glycoprotein syndromes type I with normal phosphomannomutase activity. Biochim. Biophys. Acta 1455 (1999) 167-178
13. Garami A., Mehlert A., and Ilg T. Glycosylation defects and virulence phenotypes of Leishmania mexicana phosphomannomutase and dolicholphosphate-mannose synthase gene deletion mutants. Mol. Cell. Biol. 21 (2001) 8168-8183
14. Silvaggi N.R., Zhang C., Lu Z., Dai J., Dunaway-Mariano D., and Allen K.N. The X-ray crystal structures of human alpha-phosphomannomutase 1 reveal the structural basis of congenital disorder of glycosylation type 1a. J. Biol. Chem. 281 (2006) 14918-14926
15. Davis A.J., Perugini M.A., Smith B.J., Stewart J.D., Ilg T., Hodder A.N., and Handman E. Properties of GDP-mannose pyrophosphorylase, a critical enzyme and drug target in Leishmania mexicana. J. Biol. Chem. 279 (2004) 12462-12468
16. Koonin E.V., and Tatusov R.L. Computer analysis of bacterial haloacid dehalogenases defines a large superfamily of hydrolases with diverse specificity. Application of an iterative approach to database search. J. Mol. Biol. 244 (1994) 125-132
17. Roberts A., Lee S.Y., McCullagh E., Silversmith R.E., and Wemmer D.E. Ybiv from Escherichia coli K12 is a HAD phosphatase. Proteins: Struct. Funct. Genet. 58 (2005) 790-801
18. Lawrence M.C., and Colman P.M. Shape complementarity at protein/protein interfaces. J. Mol. Biol. 234 (1993) 946-950
19. Holm L., and Sander C. Mapping the protein universe. Science 273 (1996) 595-603
20. CCP4. The CCP4 suite: programs for protein crystallography. Acta Crystallog. sect. D 50 (1994) 760-763
21. Lahiri S.D., Zhang G., Dunaway-Mariano D., and Allen K.N. The pentacovalent phosphorus intermediate of a phosphoryl transfer reaction. Science 299 (2003) 2067-2071
22. McMahon-Pratt D., and Alexander J. Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?. Immunol. Rev. 201 (2004) 206-224
23. Ilgoutz S.C., and McConville M.J. Function and assembly of the Leishmania surface coat. Int. J. Parasitol. 31 (2001) 899-908
24. Ilg T. Lipophosphoglycan is not required for infection of macrophages or mice by Leishmania mexicana. EMBO J. 19 (2000) 1953-1962
25. Wang W., Kim R., Jancarik J., Yokota H., and Kim S.H. Crystal structure of phosphoserine phosphatase from Methanococcus jannaschii, a hyperthermophile, at 1.8 Å resolution. Structure 9 (2001) 65-71
26. Morais M.C., Zhang W., Baker A.S., Zhang G., Dunaway-Mariano D., and Allen K.N. The crystal structure of Bacillus cereus phosphonoacetaldehyde hydrolase: insight into catalysis of phosphorus bond cleavage and catalytic diversification within the HAD enzyme superfamily. Biochemistry 39 (2000) 10385-10396
27. Fieulaine S., Lunn J.E., Borel F., and Ferrer J.L. The structure of a cyanobacterial sucrose-phosphatase reveals the sugar tongs that release free sucrose in the cell. Plant Cell 17 (2005) 2049-2058
28. Allen K.N., and Dunaway-Mariano D. Phosphoryl group transfer: evolution of a catalytic scaffold. Trends Biochem. Sci. 29 (2004) 495-503
29. Dai J., Wang L., Allen K.N., Radstorm P., and Dunaway-Mariano D. Conformational cycling in beta-phosphoglucomutase catalysis: reorientation of the beta-D-glucose 1,6-(bis)phosphate intermediate. Biochemistry 45 (2006) 7818-7824
30. Naught L.E., and Tipton P.A. Formation and reorientation of glucose 1,6-bisphosphate in the PMM/PGM reaction: transient-state kinetic studies. Biochemistry 44 (2005) 6831-6836
31. Macdonald S.J., Cameron R., Demaine D.A., Fenton R.J., Foster G., Gower D., et al. Dimeric zanamivir conjugates with various linking groups are potent, long-lasting inhibitors of influenza neuraminidase including H5N1 avian influenza. J. Med. Chem. 48 (2005) 2964-2971
32. Peisach E., Selengut J.D., Dunaway-Mariano D., and Allen K.N. X-ray crystal structure of the hypothetical phosphotyrosine phosphatase MDP-1 of the haloacid dehalogenase superfamily. Biochemistry 43 (2004) 12770-12779
33. Lu Z., Dunaway-Mariano D., and Allen K.N. HAD superfamily phosphotransferase substrate diversification: structure and function analysis of HAD subclass IIB sugar phosphatase BT4131. Biochemistry 44 (2005) 8684-8696
34. Tremblay L.W., Dunaway-Mariano D., and Allen K.N. Structure and activity analyses of Escherichia coli K-12 NagD provide insight into the evolution of biochemical function in the haloalkanoic acid dehalogenase superfamily. Biochemistry 45 (2006) 1183-1193
35. Flower R.J. The development of COX2 inhibitors. Nature Rev. Drug Discov. 2 (2003) 179-191
36. Lau C.K., Bayly C.I., Gauthier J.Y., Li C.S., Therien M., Asante-Appiah E., et al. Structure based design of a series of potent and selective non peptidic PTP-1B inhibitors. Bioorg. Med. Chem. Letters 14 (2004) 1043-1048
37. Scapin G., Patel S.B., Becker J.W., Wang Q., Desponts C., Waddleton D., et al. The structural basis for the selectivity of benzotriazole inhibitors of PTP1B. Biochemistry 42 (2003) 11451-11459
38. Matthijs G., Schollen E., Pardon E., Veiga-Da-Cunha M., Jaeken J., Cassiman J.J., and Van Schaftingen E. Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, un carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome). Nature 16 (1997) 88-92
39. Westphal V., Peterson S., Patterson M., Tournay A., Blumenthal A., Treacy E.P., and Freeze H.H. Functional significance of PMM2 mutations in mildly affected patients with congenital disorders of glycosylation Ia. Genet. Med. 3 (2001) 393-398
40. Studier F.W. Protein production by auto-induction in high density shaking cultures. Protein Expr. Purif. 41 (2005) 207-234
41. Otwinowski Z., and Minor W. Processing of X-ray Diffraction Data Collected in Oscillation Mode. In: Carter Jr. C.W., and Sweet R.M. (Eds). Methods in Enzymology: Macromolecular Crystallography, part A vol. 276 (1997), Academic Press, USA 307-326
42. Hendrickson W.A., and Ogata M. Phase determination from multiwavelength anomalous diffraction measurements. In: Carter C.W., and Sweet R.M. (Eds). Methods in Enzymology: Macromolecular Crystallography, part A vol. 276 (1997), Academic Press, USA 494-523
43. Pape T., and Schneider T.R. HKL2MAP: a graphical user interface for acromolecular phasing with SHELX programs. J. Appl. Crystallog. 37 (2004) 843-844
44. de la Fortelle E., and Bricogne G. Maximum-likelihood heavy-atom parameter refinement for multiple isomorphous replacement and multiwavelength anomalous diffraction methods. In: Carter Jr. C.W., and Sweet R.M. (Eds). Methods in Enzymolog: Macromolecular Crystallography, part A vol. 276 (1997), Academic Press, USA 472-494
45. Abrahams J.P., and Leslie A.G. Methods used in the structure determination of bovine mitochondrial F1 ATPase. Acta Crystallog. sect. D 52 (1996) 30-42
46. Lamzin V.S., and Wilson K.S. Automated refinement for protein crystallography. In: Carter Jr. C.W., and Sweet R.M. (Eds). Methods in Enzymology: Macromolecular Crystallography, part B vol. 277 (1997), Academic Press, USA 269-306
47. Shi J., Blundell T.L., and Mizuguchi K. FUGUE: sequence-structure homology recognition using environment-specific substitution tables and structure-dependent gap penalties. J. Mol. Biol. 310 (2001) 243-257
48. Kim Y., Yakunin A.F., Kuznetsova E., Xu X., Pennycooke M., Gu J., et al. Structure- and function-based characterization of a new phosphoglycolate phosphatase from Thermoplasma acidophilum. J. Biol. Chem. 279 (2004) 517-526
49. Sali A., and Blundell T.L. Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol. 234 (1993) 779-815
50. Jones T.A., Zou J.Y., Cowan S.W., and Kjeldgaard. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallog. sect. A 47 (1991) 110-119
51. Murshudov G.N., Vagin A.A., and Dodson E.J. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallog. sect. D 53 (1997) 240-255
52. Laskowski R.A., MacArthur M.W., Moss D.S., and Thornton J.M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallog. 26 (1993) 283-291
53. Freedman D.J., and Beverley S.M. Two more independent selectable markers for stable transfection of Leishmania. Mol. Biochem. Parasitol. 62 (1993) 37-44
54. Ilg T., Montgomery J., Stierhof Y.D., and Handman E. Molecular cloning and characterization of a novel repeat-containing Leishmania major gene, ppg1, that encodes a membrane-associated form of proteophosphoglycan with a putative glycosylphosphatidylinositol anchor. J. Biol. Chem. 274 (1999) 31410-31420
55. Lebowitz J.H., Coburn C.M., McMahon-Pratt D., and Beverley S.M. Development of a stable Leishmania expression vector and application to the study of parasite surface antigen genes. Proc. Natl Acad. Sci. USA 87 (1990) 9736-9740
56. Medina-Acosta E., and Cross G.A. Rapid isolation of DNA from trypanosomatid protozoa using a simple 'mini-prep' procedure. Mol. Biochem. Parasitol. 59 (1993) 327-329
57. Kedzierski L., Montgomery J., Bullen D., Curtis J., Gardiner E., Jimenez-Ruiz A., and Handman E. A leucine-rich repeat motif of Leishmania parasite surface antigen 2 binds to macrophages through the complement receptor 3. J. Immunol. 172 (2004) 4902-4906